查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1998686

體外循環機市場商機、成長要素、產業趨勢分析及2026-2035年預測。

Heart-lung Machine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球心肺體外迴圈裝置市場預計到 2025 年將達到 3.853 億美元，年複合成長率為 4.7%，到 2035 年將達到 6.067 億美元。

體外循環機市場-IMG1

市場擴張的主要驅動力是心血管疾病盛行率的上升以及全球器官移植和心臟手術數量的增加。心肺體外迴圈機（CPB），也稱為心肺體外迴圈裝置，在手術期間透過為血液供氧、清除二氧化碳和維持循環，暫時取代心臟和肺部的功能。氧合系統的改良和先進血泵的設計等技術創新提高了效率、安全性和易用性。如今，緊湊型高性能設備能夠實現更精確的循環控制，從而減少手術併發症，並使其在各種醫療環境中得到更廣泛的應用。對微創手術日益成長的需求，以及手術全期療效的改善，持續推動體外循環機在全球的應用。此外，保險報銷制度的完善、門診手術設施的擴建以及主要企業的策略投資也為市場的穩定成長提供了支持。

市場範圍
開始年份 2025
預測期 2026-2035
初始市場規模 3.853億美元
預測金額 6.067億美元
複合年成長率 4.7%

單滾輪泵浦市場預計將以4.4%的複合年成長率成長，到2035年達到3.54億美元。其受歡迎的原因在於可靠、可控的血流、成本效益以及在心血管手術中的廣泛應用。這些幫浦是醫院和新興醫療機構的首選，因為它們能夠提供穩定的體外膜氧合（ECMO），這對於需要長時間循環的手術至關重要。

預計到 2035 年，門診手術中心市場規模將達到 2.43 億美元，年複合成長率為 5.3%，而 2025 年的市場規模為 1.456 億美元。該市場的成長主要得益於門診微創心血管手術的日益普及，以及支持高效手術全期護理的緊湊、經濟高效的心肺體外迴圈設備解決方案。

美國心肺體外迴圈）設備市場預計到 2025 年將達到 1.446 億美元，並在 2026 年至 2035 年期間以 4.1% 的複合年成長率成長。每年大量的心血管手術、有利的報銷政策、大量的研發投入以及主要製造商的存在，鞏固了美國作為心肺體外迴圈設備領先市場的地位。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性通訊協定
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 心血管疾病盛行率增加
      • 器官移植手術數量增加
      • 體外循環機的技術進步
      • 老年人口增加
    • 產業潛在風險與挑戰
      • 先進的心肺體外迴圈設備高成本
      • 替代療法和微創手術的可及性
    • 市場機遇
      • 器官移植計畫的擴展增加了對先進灌注系統的需求。
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢（基於初步研究）
  • 價格分析（2025 年）（基於初步調查）
  • 人工智慧和生成式人工智慧對市場的影響
  • 客戶洞察（基於初步研究）
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品類型發布
    • 業務拓展計劃

第5章 市場估計與預測：依類型分類，2022-2035年

  • 單輥泵
  • 雙滾輪泵

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 心血管手術
  • 肺部手術
  • 急性呼吸衰竭的治療
  • 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • BRAILE
  • Edwards
  • ELITE LIFE CARE
  • EUROSETS
  • FRESENIUS MEDICAL CARE
  • GETINGE
  • HEART CARE INDIA CO
  • hemovent
  • Jarvik HEART
  • LivaNova
  • Medtronic
  • NIPRO
  • Palex
  • Philips
  • raumedic
  • TERUMO
簡介目錄
Product Code: 6060

The Global Heart-lung Machine Market was valued at USD 385.3 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 606.7 million by 2035.

Heart-lung Machine Market - IMG1

The market expansion is driven primarily by the rising prevalence of cardiovascular diseases and the increasing number of organ transplants and open-heart surgeries worldwide. Heart-lung machines, also referred to as cardiopulmonary bypass (CPB) devices, temporarily assume the functions of the heart and lungs during surgery by oxygenating blood, removing carbon dioxide, and maintaining circulation. Technological innovations, including improved oxygenator systems and advanced blood pump designs, have enhanced efficiency, safety, and usability. Compact and high-performance devices are now enabling more precise circulation control, reduced surgical complications, and broader adoption in diverse healthcare settings. The growing demand for minimally invasive procedures, coupled with improved perioperative outcomes, continues to propel the use of heart-lung machines globally. Additionally, better reimbursement frameworks, expanding outpatient surgical facilities, and strategic investments by key players are supporting steady market growth.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$385.3 Million
Forecast Value$606.7 Million
CAGR4.7%

The single roller pump segment is expected to grow at a CAGR of 4.4% to reach USD 354 million by 2035. Its popularity stems from reliable, controlled blood flow, cost-effectiveness, and widespread use in cardiac surgeries. These pumps offer stable extracorporeal membrane oxygenation, which is crucial for procedures requiring prolonged circulation, making them a preferred choice across hospitals and emerging healthcare facilities.

The ambulatory surgical centers segment accounted for USD 145.6 million in 2025 and is projected to reach USD 243 million by 2035, growing at a CAGR of 5.3%. Growth in this segment is fueled by the increasing adoption of minimally invasive cardiac procedures in outpatient settings, alongside compact, cost-efficient heart-lung machine solutions that support efficient perioperative care.

U.S. Heart-lung Machine Market reached USD 144.6 million in 2025 and is expected to grow at a CAGR of 4.1% from 2026 to 2035. High annual cardiac surgery volumes, favorable reimbursement policies, substantial R&D investment, and the presence of major manufacturers strengthen the U.S. position as a leading market for heart-lung machines.

Prominent players operating in the Global Heart-lung Machine Market include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, Hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, Raumedic, and TERUMO. Key strategies adopted by companies in the Global Heart-lung Machine Market include continuous R&D for advanced oxygenation and pump technologies, development of compact and portable devices for outpatient facilities, strategic partnerships with hospitals and surgical centers, expansion of global distribution networks, and ensuring regulatory compliance across multiple regions. Firms also focus on offering training programs, technical support, and after-sales services to improve adoption and customer loyalty, while optimizing production efficiency and supply chains to enhance competitiveness and market penetration.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Type trends
    • 2.2.3 Application
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cardiovascular disease
      • 3.2.1.2 Growing number of organ transplant surgeries
      • 3.2.1.3 Technological advancements in heart-lung machines
      • 3.2.1.4 Rising geriatric population base
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced heart-lung machines
      • 3.2.2.2 Availability of alternative and minimally invasive procedures
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of transplant programs boosting requirements for advanced perfusion systems
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by Primary Research)
  • 3.7 Pricing analysis, 2025 (Driven by Primary Research)
  • 3.8 Impact of AI and generative AI on the market
  • 3.9 Customer insights (Driven by Primary Research)
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single roller pump
  • 5.3 Double roller pump

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiac surgeries
  • 6.3 Lung surgeries
  • 6.4 Acute respiratory failure treatment
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals and clinics
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 BRAILE
  • 9.2 Edwards
  • 9.3 ELITE LIFE CARE
  • 9.4 EUROSETS
  • 9.5 FRESENIUS MEDICAL CARE
  • 9.6 GETINGE
  • 9.7 HEART CARE INDIA CO
  • 9.8 hemovent
  • 9.9 Jarvik HEART
  • 9.10 LivaNova
  • 9.11 Medtronic
  • 9.12 NIPRO
  • 9.13 Palex
  • 9.14 Philips
  • 9.15 raumedic
  • 9.16 TERUMO